ストックスクリーナーアプリを入手
5.975
1.89%
-0.115
前日終値:
$6.09
開ける：
$6.06
24時間の取引高:
10,409
Relative Volume:
0.14
時価総額：
$202.86M
収益：
$8.98M
当期純損益:
$-31.39M
株価収益率:
-4.459
EPS:
-1.34
ネットキャッシュフロー:
$-24.83M
1週間 パフォーマンス:
-2.85%
1か月 パフォーマンス:
+9.03%
6か月 パフォーマンス:
-23.30%
1年 パフォーマンス:
-31.00%
1日の値動き範囲:
$5.93
$6.06
1週間の範囲:
$5.84
$6.24
52週間の値動き範囲:
$3.895
$11.42
Profound Medical Corp Stock (PROF) Company Profile
名前
Profound Medical Corp
セクター
電話
647-476-1350
住所
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
PROF を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.975 | 202.86M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
134.44 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.32 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
395.28 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.39 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | Lake Street | Buy |
| 2024-07-16 | アップグレード | Stifel | Hold → Buy |
| 2023-11-28 | 開始されました | Stifel | Hold |
| 2023-08-04 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | ダウングレード | Jefferies | Buy → Hold |
| 2020-09-15 | 開始されました | Jefferies | Buy |
すべてを表示
Profound Medical Corp (PROF) 最新ニュース
(PRN) Stock Trading Blueprint (PRN:CA) - news.stocktradersdaily.com
Profound Medical: Top 10 Undervalued Medical Devices & Instruments Industry Stocks (PRN) - The Globe and Mail
How To Trade (PRN) (PRN:CA) - news.stocktradersdaily.com
Global Uterine Fibroids Treatment Devices Market is - GlobeNewswire
(PRN) Advanced Equity Analysis (PRN:CA) - news.stocktradersdaily.com
Following a 26% decline over last year, recent gains may please Profound Medical Corp. (TSE:PRN) institutional owners - simplywall.st
Profound Medical (NASDAQ:PROF) Shares Up 17.4% – What’s Next? - Defense World
Regulatory Affairs in Life Sciences - Fasken
Profound Medical (PROF) Advances BPH Treatment with New Module | - GuruFocus
Profound Medical announces first commercial BPH treatment using TULSA-AI - TipRanks
Profound Medical (PROF) Advances BPH Treatment with New Module | PROF Stock News - GuruFocus
Profound Medical Brief: Announcing First Commercial BPH Patient Treatment Using TULSA-PRO with TULSA-AI Volume Reduction - MarketScreener
Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction - Yahoo Finance
(PRN) Trading Performance and Risk Management (PRN:CA) - news.stocktradersdaily.com
Learn to Evaluate (PRN) using the Charts (PRN:CA) - news.stocktradersdaily.com
Profound Medical (PROF) Partners with Leonard Wheeler to Boost T - GuruFocus
Profound Medical (PROF) Partners with Leonard Wheeler to Boost TULSA-PRO Awareness | PROF Stock News - GuruFocus
Profound Medical Partners with NFL Legend Leonard Wheeler to Promote TULSA-PRO - TipRanks
Profound Medical enters agreement with former NFL player Leonard Wheeler - TipRanks
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassado - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® | PROF Stock News - GuruFocus
Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO® - The Manila Times
(PRN) Equity Market Report (PRN:CA) - news.stocktradersdaily.com
(PRN) Trading Report (PRN:CA) - news.stocktradersdaily.com
Long Term Trading Analysis for (PRN) (PRN:CA) - news.stocktradersdaily.com
Where are the Opportunities in (PRN) (PRN:CA) - news.stocktradersdaily.com
1 Magnificent Healthcare Stock Down 80% to Buy and Hold Forever - MSN
(PRN) Stock Market Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical CEO Arun Menawat buys $100,150 in shares By Investing.com - Investing.com Canada
Insider Buying: Arun Menawat Acquires Shares of Profound Medical Corp (PROF) - GuruFocus
Profound Medical CEO Arun Menawat buys $100,150 in shares - Investing.com Australia
Profound Medical targets 70%-75% growth in 2025 with new TULSA AI module launch - MSN
Arun Menawat Bought 2.1% More Shares In Profound Medical - Yahoo Finance
(PRN) Financial Trading Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical announces shareholder vote results - Investing.com Australia
Objective long/short (PRN) Report (PRN:CA) - news.stocktradersdaily.com
Profound Medical Annual General and Special Meeting of Shareholders Voting Results - The Manila Times
Profound Medical announces shareholder vote results By Investing.com - Investing.com South Africa
Profound Medical Corp. Announces Successful Shareholder Meeting Outcomes - TipRanks
Profound Medical Annual General and Special Meeting of Shareholders Voting Results | PROF Stock News - GuruFocus
Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket - Benzinga
(PRN) Pivots Trading Plans and Risk Controls (PRN:CA) - news.stocktradersdaily.com
Profound Medical First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Profound Medical Corp. (NASDAQ:PROF) Q1 2025 Earnings Call Transcript - Insider Monkey
Profound Medical stock rating downgraded at Raymond James By Investing.com - Investing.com Nigeria
Profound Medical stock rating downgraded at Raymond James - Investing.com
Profound Medical (PROF) Downgraded by Raymond James Amid Economic Concerns | PROF Stock News - GuruFocus
Profound Medical Q1 2025 revenue jumps 82% - Medical Buyer
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... By GuruFocus - Investing.com Canada
Profound Medical Corp (PROF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Profound Medical Corp (PROF) 財務データ
収益
当期純利益
現金流量
EPS
Profound Medical Corp (PROF) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
0.19%
大文字化:
|
ボリューム (24 時間):